FMP
Acasti Pharma Inc.
ACST
NASDAQ
Inactive Equity
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
3.37 USD
0.13 (3.86%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Prashant Kohli
sector
Healthcare
industry
Biotechnology
website
https://www.acastipharma.comexchange
NASDAQ
Description
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
CIK
0001444192
ISIN
CA00430K8656
CUSIP
00430K402
Address
3009 boulevard de la Concorde ...
Phone
450 687 2262
Country
CA
Employee
32
IPO Date
Feb 7, 2012
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
ACST Financial Summary
CIK
0001444192
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
00430K402
ISIN
CA00430K8656
Country
CA
Price
3.37
Beta
1.52
Volume Avg.
33.25k
Market Cap
34.17M
Shares
-
52-Week
1.98-3.6
DCF
1.74
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-2.36
P/B
-
Website
https://www.acastipharma.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ACST News
It looks like there's no news available.
